Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 25;9(8):7775-82.
doi: 10.1021/acsnano.5b01696. Epub 2015 Jun 25.

Nanoparticle-Stabilized Capsules for the Treatment of Bacterial Biofilms

Affiliations

Nanoparticle-Stabilized Capsules for the Treatment of Bacterial Biofilms

Bradley Duncan et al. ACS Nano. .

Abstract

Bacterial biofilms are widely associated with persistent infections. High resistance to conventional antibiotics and prevalent virulence makes eliminating these bacterial communities challenging therapeutic targets. We describe here the fabrication of a nanoparticle-stabilized capsule with a multicomponent core for the treatment of biofilms. The peppermint oil and cinnamaldehyde combination that comprises the core of the capsules act as potent antimicrobial agents. An in situ reaction at the oil/water interface between the nanoparticles and cinnamaldehyde structurally augments the capsules to efficiently deliver the essential oil payloads, effectively eradicating biofilms of clinically isolated pathogenic bacteria strains. In contrast to their antimicrobial action, the capsules selectively promoted fibroblast proliferation in a mixed bacteria/mammalian cell system making them promising for wound healing applications.

Keywords: Pickering emulsion; biofilm; phytochemicals; self-assembly; silica nanoparticles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Confocal micrographs of a) P-Cap and b) CP-Cap. The nanoparticles’ cores are labeled with fluorescein (green fluorescence) and the oil phases are loaded with Nile red (red fluorescence). Scale bars are 20 µm. c) XPS spectra showing N 1s core levels arising from SiO2 NPs and CP-Cap. d) Water contact angles of silica nanoparticles following incubation with varying concentrations of cinnamaldehyde.
Figure 2
Figure 2
Representative 3D projection of confocal image stacks of 1 day-old E. coli DH5α biofilm after 3 hrs treatment with a) CP-Cap containing FITC-labeled SiO2 NP, b) P-Cap containing FITC-labeled SiO2 NP, and c) FITC-labeled SiO2 NP at 20 % (v/v % of 2 % emulsion) concentration. Upper panels are projection at 247° angle turning along Y axis and lower panels are at 270° angle turning along Y axis. Scale bars are 20 µm.
Figure 3
Figure 3
Viability of 1 day-old a) P. aeruginosa (CD-1006) b) E. coli DH5α c) S. aureus (CD-489) d) E. cloacae complex (CD-1412) biofilms after 3 hrs treatment with CP-Cap, P-Cap, SiO2 NP, and peppermint oil at different emulsion concentrations (v/v % of 2 % emulsion). The data are average of triplicates and the error bars indicate the standard deviations.
Figure 4
Figure 4
Viability of 3T3 fibroblast cells and E. coli biofilms in the co-culture model after 3 hrs treatment with a) CP-Cap, b) P-Cap, c) SiO2 NP, and d) peppermint oil at different emulsion concentrations (v/v % of 2 % emulsion). Scatters and lines represent 3T3 fibroblast cell viability. Bars represent log10 of colony forming units in biofilms. The data are average of triplicates and the error bars indicate the standard deviations.
Scheme 1
Scheme 1
a) Schematic depiction of the strategy used to generate antimicrobial capsules. Peppermint oil with dissolved cinnamaldehyde is emulsified into an aqueous suspension of amine functionalized silica nanoparticles. Cinnamaldehyde within the oil reacts with the amines on the nanoparticles at the oil/water interface to create a multimodal delivery vehicle. b) Capsules interact with biofilm through electrostatic complementarity. Capsules release their payload disrupting the biofilm, eliminating the bacteria.

References

    1. Costerton JW, Stewart PS, Greenburg EP. Bacterial Biofilms: A Common Cause of Persistent Infections. Science. 1999;284:1318–1322. - PubMed
    1. Lindsay D, von Holy A. Bacterial Biofilms within the Clinical Setting: What Healthcare Professionals Should Know. J. Hosp. Infect. 2006;64:313–325. - PubMed
    1. Costerton JW, Montanaro L, Arciola CR. Biofilm in Implant Infections: Its Production and Regulation. Int. J. Artif. Organs. 2005;28:1062–1068. - PubMed
    1. Busscher HJ, Rinastiti M, Siswomihardjo W, van der Mei HC. Biofilm Formation on Dental Restorative and Implant Materials. J. Dent. Res. 2010;89:657–665. - PubMed
    1. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The Application of Biofilm Science to the Study and Control of Chronic Bacterial Infections. J. Clin. Invest. 2003;112:1466–1477. - PMC - PubMed

Publication types

MeSH terms